Azithromycin/Bicillin Syphilis

PHASE3CompletedINTERVENTIONAL
Enrollment

593

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

August 31, 2007

Study Completion Date

March 31, 2009

Conditions
Syphilis
Interventions
DRUG

Azithromycin

Single 2 gram oral dose (4 tablets) at Day 1.

DRUG

Benzathine Penicillin

Supplied in pre-filled syringes containing 1.2 million units of benzathine penicillin; 2.4 million units administered intramuscularly at Day 1, in one or both buttocks.

DRUG

Doxycycline

Baseline visit, 28 capsules dispensed, for a dose of 100 mg twice a day (BID).

Trial Locations (10)

101

Laboratoire National de Reference sur le VIH/SIDA (LNR), Analamanga

401

Hopitaly Mahabibo, Mahajanga Majunga

27514

University of North Carolina at Chapel Hill, Chapel Hill

46202

Indiana University, Indianapolis

35249-0001

University of Alabama Hospital - Infectious Diseases, Birmingham

70112-2865

Louisiana State University Health Sciences Center - Infectious Diseases, New Orleans

21287-0005

Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore

27599-7030

University of North Carolina School of Medicine - Center for Infectious Diseases, Chapel Hill

27701-3720

Durham County Health Department, Durham

Unknown

Hopitaly Kely, Toamasina

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00031499 - Azithromycin/Bicillin Syphilis | Biotech Hunter | Biotech Hunter